Please assess the completion status of the following clinical trial:

Trial Title: Study of Immunity at the Genital Mucosa of HIV-1 Infected and Healthy Women

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: None
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Free, informed and signed consent~* Person affiliated or beneficiary of a social security system or the Universal Health Coverage~* Female~* No menopausal, aged 18 to 45 years,~* Under oral contraceptive or implant~* Urine pregnancy test negative~* HBsAg and HCV serology negative~* Cervicovaginal smear normal older than one year,~* Normal vaginal smear dated within one year~For healthy women~\* HIV serology negative~For infected women~* HIV-1 infection checked by western-blot and/or the detection of HIV-RNA~* CD4+ T cells \>350/mm3 (several tests, since 6 months)~* Viral load \<40 copies/ml since 6 months~* Treated with antiretroviral drugs since 6 months~Exclusion Criteria:~* Significant history of vaginal pathology (malignancy, prolapse)~* Hysterectomy, conization~* History of abnormal Pap smear in the previous year (ASC-US, AG-US and LSIL and high grade according to Bethesda).~* Breakthrough bleeding;~* Clinical symptoms suggestive of genital infection within 10 days prior to the examination of the study,~* Antibiotic systemically within 10 days prior to the examination of the study,~* Immunosuppressive or immunomodulatory treatment in the last six months and corticosteroids (\> 20 mg / day for 5 days) in last 3 months~* Presence of other sexually transmitted infection detected in samples at pre-inclusion visit and ongoing at V1 visit (Mycoplasma, Chlamydia, gonorrhea, Trichomonas, Candida albicans and Syphilis)~* A person participating in another research including a period of exclusion still ongoing selection~* Population called vulnerable (minors, persons under guardianship, or deprived of liberty by a judicial decision.

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 45 Years
- Healthy Volunteers: t

Study Arms:
- Healthy women volunteers (Type: OTHER): Healthy women volunteers with vaginal swabs by washing and cytobrush
- HIV-1 infected women (Type: OTHER): HIV-1 infected women with vaginal swabs by washing and cytobrush

Based on this trial design, predict the completion outcome and termination type (if applicable).